305 related articles for article (PubMed ID: 26220736)
1. Addition of a single methyl group to a small molecule sodium channel inhibitor introduces a new mode of gating modulation.
Wang L; Zellmer SG; Printzenhoff DM; Castle NA
Br J Pharmacol; 2015 Oct; 172(20):4905-18. PubMed ID: 26220736
[TBL] [Abstract][Full Text] [Related]
2. PF-06526290 can both enhance and inhibit conduction through voltage-gated sodium channels.
Wang L; Zellmer SG; Printzenhoff DM; Castle NA
Br J Pharmacol; 2018 Jul; 175(14):2926-2939. PubMed ID: 29791744
[TBL] [Abstract][Full Text] [Related]
3. Biphasic voltage-dependent inactivation of human Na
Godazgar M; Zhang Q; Chibalina MV; Rorsman P
J Physiol; 2018 May; 596(9):1601-1626. PubMed ID: 29441586
[TBL] [Abstract][Full Text] [Related]
4. The Selective Nav1.7 Inhibitor, PF-05089771, Interacts Equivalently with Fast and Slow Inactivated Nav1.7 Channels.
Theile JW; Fuller MD; Chapman ML
Mol Pharmacol; 2016 Nov; 90(5):540-548. PubMed ID: 27587537
[TBL] [Abstract][Full Text] [Related]
5. A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability.
Payne CE; Brown AR; Theile JW; Loucif AJ; Alexandrou AJ; Fuller MD; Mahoney JH; Antonio BM; Gerlach AC; Printzenhoff DM; Prime RL; Stockbridge G; Kirkup AJ; Bannon AW; England S; Chapman ML; Bagal S; Roeloffs R; Anand U; Anand P; Bungay PJ; Kemp M; Butt RP; Stevens EB
Br J Pharmacol; 2015 May; 172(10):2654-70. PubMed ID: 25625641
[TBL] [Abstract][Full Text] [Related]
6. Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels.
Cregg R; Cox JJ; Bennett DL; Wood JN; Werdehausen R
Br J Pharmacol; 2014 Oct; 171(19):4455-63. PubMed ID: 24866741
[TBL] [Abstract][Full Text] [Related]
7. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.
Dustrude ET; Wilson SM; Ju W; Xiao Y; Khanna R
J Biol Chem; 2013 Aug; 288(34):24316-31. PubMed ID: 23836888
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist.
Ahuja S; Mukund S; Deng L; Khakh K; Chang E; Ho H; Shriver S; Young C; Lin S; Johnson JP; Wu P; Li J; Coons M; Tam C; Brillantes B; Sampang H; Mortara K; Bowman KK; Clark KR; Estevez A; Xie Z; Verschoof H; Grimwood M; Dehnhardt C; Andrez JC; Focken T; Sutherlin DP; Safina BS; Starovasnik MA; Ortwine DF; Franke Y; Cohen CJ; Hackos DH; Koth CM; Payandeh J
Science; 2015 Dec; 350(6267):aac5464. PubMed ID: 26680203
[TBL] [Abstract][Full Text] [Related]
9. Recombinant PaurTx-3, a spider toxin, inhibits sodium channels and decreases membrane excitability in DRG neurons.
Chen M; Peng S; Wang L; Yang L; Si Y; Zhou X; Zhang Y; Liu Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):958-964. PubMed ID: 33004176
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel Na
Kornecook TJ; Yin R; Altmann S; Be X; Berry V; Ilch CP; Jarosh M; Johnson D; Lee JH; Lehto SG; Ligutti J; Liu D; Luther J; Matson D; Ortuno D; Roberts J; Taborn K; Wang J; Weiss MM; Yu V; Zhu DXD; Fremeau RT; Moyer BD
J Pharmacol Exp Ther; 2017 Jul; 362(1):146-160. PubMed ID: 28473457
[TBL] [Abstract][Full Text] [Related]
11. Mutant cycle analysis with modified saxitoxins reveals specific interactions critical to attaining high-affinity inhibition of hNaV1.7.
Thomas-Tran R; Du Bois J
Proc Natl Acad Sci U S A; 2016 May; 113(21):5856-61. PubMed ID: 27162340
[TBL] [Abstract][Full Text] [Related]
12. Optical electrophysiology for probing function and pharmacology of voltage-gated ion channels.
Zhang H; Reichert E; Cohen AE
Elife; 2016 May; 5():. PubMed ID: 27215841
[TBL] [Abstract][Full Text] [Related]
13. Lidocaine Binding Enhances Inhibition of Nav1.7 Channels by the Sulfonamide PF-05089771.
Jo S; Bean BP
Mol Pharmacol; 2020 Jun; 97(6):377-383. PubMed ID: 32193331
[TBL] [Abstract][Full Text] [Related]
14. Visceral and somatic pain modalities reveal Na
Hockley JR; González-Cano R; McMurray S; Tejada-Giraldez MA; McGuire C; Torres A; Wilbrey AL; Cibert-Goton V; Nieto FR; Pitcher T; Knowles CH; Baeyens JM; Wood JN; Winchester WJ; Bulmer DC; Cendán CM; McMurray G
J Physiol; 2017 Apr; 595(8):2661-2679. PubMed ID: 28105664
[TBL] [Abstract][Full Text] [Related]
15. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.
Sheets PL; Jackson JO; Waxman SG; Dib-Hajj SD; Cummins TR
J Physiol; 2007 Jun; 581(Pt 3):1019-31. PubMed ID: 17430993
[TBL] [Abstract][Full Text] [Related]
16. 3'-O-Methylorobol Inhibits the Voltage-Gated Sodium Channel Nav1.7 with Anti-Itch Efficacy in A Histamine-Dependent Itch Mouse Model.
Zhang F; Wu Y; Xue S; Wang S; Zhang C; Cao Z
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31805638
[TBL] [Abstract][Full Text] [Related]
17. Subtype specificity of scorpion beta-toxin Tz1 interaction with voltage-gated sodium channels is determined by the pore loop of domain 3.
Leipold E; Hansel A; Borges A; Heinemann SH
Mol Pharmacol; 2006 Jul; 70(1):340-7. PubMed ID: 16638971
[TBL] [Abstract][Full Text] [Related]
18. Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels.
McCormack K; Santos S; Chapman ML; Krafte DS; Marron BE; West CW; Krambis MJ; Antonio BM; Zellmer SG; Printzenhoff D; Padilla KM; Lin Z; Wagoner PK; Swain NA; Stupple PA; de Groot M; Butt RP; Castle NA
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):E2724-32. PubMed ID: 23818614
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel Na
Gilchrist JM; Yang ND; Jiang V; Moyer BD
Mol Pharmacol; 2024 Feb; 105(3):233-249. PubMed ID: 38195157
[TBL] [Abstract][Full Text] [Related]
20. Reduced availability of voltage-gated sodium channels by depolarization or blockade by tetrodotoxin boosts burst firing and catecholamine release in mouse chromaffin cells.
Vandael DH; Ottaviani MM; Legros C; Lefort C; Guérineau NC; Allio A; Carabelli V; Carbone E
J Physiol; 2015 Feb; 593(4):905-27. PubMed ID: 25620605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
